Who we are
Why eliminate viral hepatitis?
Viral hepatitis is a large global health threat. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection caused an estimated 1.3 million deaths in 2016 from cirrhosis and liver cancer. Approximately 325 million persons are living with HBV or HCV infection and an estimated 2.8 million new chronic infections occur annually.
The Coalition for Global Hepatitis Elimination (CGHE)
To catalyze progress toward achievement of the goals for viral hepatitis elimination globally, the Task Force for Global Health (TFGH) launched the Coalition for Global Hepatitis Elimination (CGHE) in July 2019.
Modeled after other TFGH disease elimination programs, the CGHE provides services to assist the planning, implementation and evaluation of national and sub-national programs to eliminate Hepatitis B virus (HBV) and hepatitis C virus (HCV) transmission and disease.
The Task Force for Global Health (TFGH)
The TFGH is an ideal home for CGHE. Started in 1984 by Dr. William Foege, a former CDC director and a leader of the successful global campaign to eradicate smallpox, the TFGH is the organization with the greatest experience globally in supporting disease elimination initiatives. From the start of the TFGH, Dr. Foege, joined by Drs. Walt Dowdle, Alan Hinman and other TFGH senior scientists led development of disease elimination and eradication as a field of public health. Their academic work established standard definitions for disease elimination and eradication, criteria for selecting feasible targets and essential components of successful programs. This academic work led to a global consensus that disease elimination and eradication are the ultimate goals of public health resulting in large benefits in lives saved and assuring health equity.